Business

Notification of Transactions

Spire Healthcare Group plc announced that on May 18, 2026, Executive Directors Justin Ash and Harbant Samra exercised vested awards. Justin Ash exercised 547,061 nil-cost options from his 2021 LTIP awards and 116,473 from his 2023 DSBP awards, retaining 289,942 and 61,730 shares respectively after tax, bringing his total holding to 1,652,131 ordinary shares. Harbant Samra exercised 37,463 nil-cost options from his 2023 LTIP awards, retaining 19,855 shares after tax, resulting in a total holding of 74,932 ordinary shares. Disclaimer*

Spire Healthcare Group PlcMay 19, 20263
Notification of Transactions

About this update from Spire Healthcare Group Plc

Spire Healthcare Group plc (the Company ) Notification of Transactions of Persons Discharging Managerial Responsibilities     19 May 2026   Exercise of awards The Company announces that, on 18 May 2026, the Executive Directors of the Company, exercised vested awards as follows:   (1)  Justin Ash exercised both his: ·    Long Term Incentive Plan awards in the Company that were granted on 18 March 2021 (the 2021 LTIP awards ). 2021 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2023 Annual Report and Accounts. On vesting in March 2024, the 2021 LTIP awards were subject to a further two-year holding period which ended on 19 March 2026; and ·    Deferred Share Bonus Plan awards that were granted on 15 March 2023 (the 2023 DSBP awards ). 2023 DSBP awards were subject to a three-year holding period which ended on 15 March 2026; and   (2)  Harbant Samra exercised his Long Term Incentive Plan awards in the Company that were granted on 15 March 2023 (the 2023 LTIP awards ). 2023 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2025 Annual Report and Accounts.   Following the exercise by the Directors of these awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:     Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due Justin Ash 2021 LTIP (in the form of nil-cost options)   547,061 289,942 Justin Ash   2023 DSBP (in the form of nil-cost options)   116,473 61,730 Total number of shares retained 351,672   Following the transactions, Justin Ash holds 1,652,131 ordinary shares in the Company.     Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due Harbant Samra 2023 LTIP (in the form of nil-cost options)   37,463 19,855 Total number of shares retained 19,855   Following the transactions, Harbant Samra holds 74,932 ordinary shares in the Company. Name of contact and telephone number for queries: Mantraraj Budhdev Group General Counsel, Chief People Officer and Company Secretary Spire Healthcare Group plc Tel: 07787 283848     Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them   1 Details of the person discharging managerial responsibilities/person closely associated a) Name   Justin Ash 2 Reason for the notification a) Position/status   Chief Executive Officer b) Initial notification /Amendment   Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name   Spire Healthcare Group plc b) LEI 213800IBJPW3SE2RA350 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 1 pence each   GB00BNLPYF73 b) Nature of the transaction Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.   Following the exercise by Mr Ash of his award over 547,061 ordinary shares and after the satisfaction of taxes due, a balance of 289,942 ordinary shares were transferred to him, which he has retained.   c) Price(s) and volume(s) Price(s) Volume(s) Nil   289,942   d) Aggregated information - Aggregated volume - Price As above e) Date of the transaction 2026-05-18 f) Place of the transaction Outside a trading venue     1 Details of the person discharging managerial responsibilities/person closely associated a) Name   Justin Ash 2 Reason for the notification a) Position/status   Chief Executive Officer b) Initial notification /Amendment   Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name   Spire Healthcare Group plc b) LEI 213800IBJPW3SE2RA350 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 1 pence each   GB00BNLPYF73 b) Nature of the transaction Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Deferred Share Bonus Plan.   Following the exercise by Mr Ash of his award over 116,473 ordinary shares and after the satisfaction of taxes due, a balance of 61,730 ordinary shares were transferred to him, which he has retained.   c) Price(s) and volume(s) Price(s) Volume(s) Nil   61,730     d) Aggregated information - Aggregated volume - Price As above e) Date of the transaction 2026-05-18 f) Place of the transaction Outside a trading venue   1 Details of the person discharging managerial responsibilities/person closely associated a) Name   Harbant Samra 2 Reason for the notification a) Position/status   Chief Financial Officer b) Initial notification /Amendment   Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name   Spire Healthcare Group plc b) LEI 213800IBJPW3SE2RA350 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 1 pence each   GB00BNLPYF73 b) Nature of the transaction Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.   Following the exercise by Mr Samra of his award over 37,463 ordinary shares and after the satisfaction of taxes due, a balance of 19,855 ordinary shares were transferred to him, which he has retained.   c) Price(s) and volume(s) Price(s) Volume(s) Nil   19,855   d) Aggregated information - Aggregated volume - Price As above e) Date of the transaction 2026-05-18 f) Place of the transaction Outside a trading venue  

View stock analysis, news, and events for Spire Healthcare Group Plc

More from Spire Healthcare Group Plc

All Spire Healthcare Group Plc news →